| (Values in U.S. Thousands) | Mar, 2019 | Dec, 2018 | Sep, 2018 | Jun, 2018 | Mar, 2018 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | 0 | 0 | 0 | 0 | 0 |
| Net Income Growth | unch | unch | unch | unch | unch |
Avita Medical (AVMXY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Avita Medical Limited operates as a medical technology company. The company develops and distributes products in Regenerative and Respiratory Medicine. Avita's regenerative and tissue-engineered products provide revolutionary solutions utilizing the patient's own skin and the regenerative capability of the human body to treat a wide range of wounds, scars and skin defects. The Company's lead product, ReCell(R) Spray'On Skin (R), is used in a wide variety of burns, plastic, reconstructive and cosmetic procedures. It manufactures and sells a range of spacers for the paediatric, adolescent and adult market. Avita Medical Limited is headquartered in Cambridge, the United Kingdom.